Effect of a topical steroid on gene expressions for chemokines in mice with contact hypersensitivity

International Immunopharmacology

Volumn 4, Issue 1, 2004, Pages 57-69

  Mitsui, Gaku ^a,b   Hirano, Takeo ^a   Niwano, Yoshimi ^b   Mitsui, Kazutaka ^b   Ohara, Osamu ^a,c   Yanagihara, Satoshi ^b   Kato, Masatoshi ^b  

^a KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^b Sato Pharmaceutical Co Ltd   (Japan)

^c RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

Chemokine genes; Contact hypersensitivity; Corticosteroid; RT PCR

Indexed keywords

CHEMOKINE; CORTICOSTEROID; DIFLUCORTOLONE VALERATE; MESSENGER RNA; PICRYL CHLORIDE; TEXMETEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTACT ALLERGY; CONTROLLED STUDY; DRUG EFFECT; EAR DISEASE; EDEMA; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENE EXPRESSION; INFLAMMATORY CELL; MALE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 1242329062     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.10.005     Document Type: Article

References (54)

1. Macatonia S.E., Edwards A.J., Knight S.C. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology. 59:1986;509-514.
2. Macatonia S.E., Knight S.C., Edwards A.J., Griffiths S., Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166:1987;1654-1667.
3. Silberberg-Sinakin I., Thorbecke G.J., Baer R.L., Rosenthal S.A., Berezowsky V. Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol. 25:1976;137-151.
4. Watanabe H., Unger M., Tubel B., Wang B., Sauder D.N. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J. Interferon Cytokine Res. 22:2002;407-412.
5. Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today. 19:1998;37-44.
6. Askenase P.W. Yes T cells, but three different T cells (αβ, γδ and NK T cells), and also B-1 cells mediate contact sensitivity. Clin. Exp. Immunol. 125:2001;345-350.
7. + Type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165:2000;6783-6790.
8. Akiba H., Kehren J., Ducluzeau M.T., Krasteva M., Horand F.et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168:2002;3079-3087.
9. + T cell-mediated contact hypersensitivity. J. Exp. Med. 189:1999;779-786.
10. Wang B., Feliciani C., Freed I., Cai Q., Sauder D.N. Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies. J. Leukoc. Biol. 70:2001;185-191.
11. Piguet P.F., Grau G.E., Hauser C., Vassali P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173:1991;673-679.
12. Shornick L.P., De Togni P., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R.W.et al. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J. Exp. Med. 183:1996;1427-1436.
13. Lu B., Ebensperger C., Dembic Z., Wang Y., Kvatyuk M., Lu T.et al. Targeted disruption of the interferon-γ receptor 2 gene results in severe immune defects in mice. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8233-8238.
14. Wang B., Zhuang L., Fujisawa H., Shinder G.A., Feliciani C., Shivji G.M.et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162:1999;277-283.
15. Miller M.D., Krangel M.S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:1992;17-46.
16. Oppenheim J.J., Zachariae C.O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:1991;617-648.
17. Sebastiani S., Albanesi C., Pità O.D., Puddu P., Cavani A., Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch. Dermatol. Res. 293:2002;552-559.
18. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2002;121-127.
19. Dieu-Nosjean M.C., Massacrier C., Homey B., Vanbervliet B., Pin J.J.et al. Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192:2000;705-717.
20. Geiser T., Dewald B., Ehrengruber M.U., Clark-Lewis I., Baggiolini M. The interleukin-8-related chemotactic cytokines GROα, GROβ, and GROγ activate human neutrophil and basophil leukocytes. J. Biol. Chem. 268:1993;15419-15424.
21. Bozic C.R., Kolakowski L.F. Jr., Gerard N.P., Garcia-Rodriguez C., von Uexkull-Guldenband C.et al. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154:1995;6048-6057.
22. Dilulio N.A., Engeman T., Armstrong D., Tannenbaum C., Hamilton T.A., Fairchild R.L. Groα-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity. Eur. J. Immunol. 29:1999;3485-3495.
23. Luster A.D., Rothenberg M.E. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukoc. Biol. 62:1997;620-633.
24. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L.et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:1996;963-969.
25. Gautam S., Battisto J., Major J.A., Armstrong D., Stoler M., Hamilton T.A. Chemokine expression in trinitrochlorobenzene-mediated contact hypersensitivity. J. Leukoc. Biol. 55:1994;452-460.
26. Enk A.H., Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. U. S. A. 89:1992;1398-1402.
27. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., Luster A.D. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:2002;3195-3204.
28. Cavajal Rosado V.M. Topical treatment of various dermatosis with difluocortolone valerianate. (ointment) Double blind comparative study. Prensa Med. Mex. 41:1976;183-185.
29. Filho J.L., Lacet I.G., Calheiros de Lima M.E., Santos Oliveira V.L. Treatment of inflammatory dermatoses with difluocortolone valerate. Z. Hautkr. 51(Suppl. 1):1976;40-42.
30. Igawa K., Yokozeki H., Miyazaki Y., Minatohara K., Satoh T.et al. Topical glucocorticoids application induced an augmentation in the expression of IL-1alpha while inhibiting the expression of IL-10 in the epidermis in murine contact hypersensitivity. Clin. Exp. Allergy. 31:2001;485-494.
31. Greaves D.R., Wang W., Dairaghi D.J., Dieu M.C., Saint-Vis B.et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J. Exp. Med. 186:1997;837-844.
32. Power C.A., Church D.J., Meyer A., Alouani S., Proudfoot A.E.et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3α from lung dendritic cells. J. Exp. Med. 186:1997;825-835.
33. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:1994;97-179.
34. Mitsui G., Mitsui K., Hirano T., Ohara O., Kato M., Niwano Y. Kinetic profiles of sequential gene expressions for chemokines in mice with contact hypersensitivity. Immunol. Lett. 86:2003;191-197.
35. Lowe N.J., Virgadamo F., Stoughton R.B. Anti-inflammatory properties of a prostaglandin antagonist, a corticosteroid and indomethacin in experimental contact dermatitis. Br. J. Dermatol. 96:1977;433-438.
36. Back O., Egelrud T. Topical glucocorticoids and suppression of contact sensitivity. A mouse bioassay of anti-inflammatory effects. Br. J. Dermatol. 112:1985;539-545.
37. Almawi W.Y., Beyhum H.N., Rahme A.A., Rieder M.J. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60:1996;563-572.
38. Proost P., De Wolf-Peeters C., Conings R., Opdenakker G., Billiau A., Van Damme J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol. 150:1993;1000-1010.
39. Sekido N., Mukaida N., Harada A., Nakanishi I., Watanabe Y., Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 365:1993;654-657.
40. Broaddus V.C., Boylan A.M., Hoeffel J.M., Kim K.J., Sadick M.et al. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J. Immunol. 152:1994;2960-2967.
41. Kunkel S.L., Lukacs N., Kasama T., Strieter R.M. The role of chemokines in inflammatory joint disease. J. Leukoc. Biol. 59:1996;6-12.
42. Aziz K.E., Wakefield D. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by β-estradiol, progesterone, and dexamethasone. Cell Immunol. 167:1996;79-85.
43. Yoshida N., Yoshikawa T., Nakamura Y., Takenaka S., Sakamoto K.et al. Methylprednisolone inhibits neutrophil-endothelial cell interactions induced by interleukin-1β under flow conditions. Life Sci. 60:1997;2341-2347.
44. Wheller S.K., Perretti M. Dexamethasone inhibits cytokine-induced intercellular adhesion molecule-1 up-regulation on endothelial cell lines. Eur. J. Pharmacol. 331:1997;65-71.
45. Goebeler M., Trautmann A., Voss A., Brocker E.V., Toksoy A., Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am. J. Pathol. 158:2001;431-440.
46. + T cells in IP-10 expression. J. Dermatol. Sci. 28:2002;234-241.
47. Rahman I. Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem. Pharmacol. 64:2002;935-942.
48. Adcock I.M. Transcription factors as activators of gene transcription: AP-1 and NF-κB. Monaldi. Arch. Chest. Dis. 52:1997;178-186.
49. Payne D.N., ADCOCK I.M. Molecular mechanisms of corticosteroid actions. Paediatr. Respir. Rev. 2:2001;145-150.
50. Adcock I.M., Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol. Cell Biol. 79:2001;376-384.
51. Hiroi M., Ohmori Y. The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-κB for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-γ gene. J. Biol. Chem. 278:2003;651-660.
52. Fujiie S., Hieshima K., Izawa D., Nakayama T., Fujisawa R.et al. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3α/CCL20 in mucosal epithelial cells through NF-κB. Int. Immunol. 13:2001;1255-1263.
53. Rimbach G., Valacchi G., Canali R., Virgili F. Macrophages stimulated with IFN-γ activate NF-κB and induce MCP-1 gene expression in primary human endothelial cells. Mol. Cell. Biol. Res. Commun. 3:2000;238-242.
54. Ohmori Y., Hamilton T.A. Cooperative interaction between interferon (IFN) stimulus response element and κB sequence motifs controls IFNγ- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J. Biol. Chem. 268:1993;6677-6688.